Results 121 to 130 of about 105,961 (251)

PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4+ lymphocytes

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 8, Page 2949-2959, August 2026.
Background Female sex hormones used in feminizing hormone therapy (FHT) may influence activation and persistence of HIV pre‐exposure prophylaxis (PrEP) medications. The clinical relevance of this interaction remains unclear, particularly for transgender and cisgender women (TGW and CGW).
Elizabeth Hastie   +10 more
wiley   +1 more source

Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020? [PDF]

open access: yes, 2009
BACKGROUND: Trachoma has been endemic in The Gambia for decades. National trachoma control activities have been in place since the mid-1980's, but with no mass antibiotic treatment campaign.
Chrissy H Roberts   +32 more
core   +1 more source

The Aetiology and Treatment Outcomes of Epididymo-Orchitis: A 2025 Clinic-Based Review

open access: yesVenereology
Background: Epididymo-orchitis can be caused by sexually transmitted pathogens, including Neisseria gonorrhoeae, Chlamydia trachomatis, and Mycoplasma genitalium, or entero-bacteria.
Jim Abi Frem   +4 more
doaj   +1 more source

Advancing Tumor Treatment Through Artificial Intelligence and Mathematical Modeling: A Comprehensive Review

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Solid tumors emerge from uncontrolled cell division and interactions with neighboring cells that influence their growth and resistance to therapy. Anti‐cancer drugs are developed to disrupt these processes, but they often damage healthy cells, making treatment difficult to manage safely and effectively. As the global cancer
Mohsin Kamran   +3 more
wiley   +1 more source

Repeated, low dose Chlamydia infections trigger aberrant immune responses and weakened host resistance against secondary challenge [PDF]

open access: yes, 2022
Chlamydia trachomatis infections endanger women’s health, but translational gaps between animal models and human disease states persist. I compared immune responses in mice receiving repeated, low dose infections (5X) with Chlamydia muridarum to those ...
Surette, Monica
core  

De novo or Salvage? Nucleotide Availability as a Driver of Bacterial Adaptation and Virulence

open access: yesMicrobiologyOpen, Volume 15, Issue 4, August 2026.
Bacterial pathogens survive in different host environments by switching between making nucleotides by de novo synthesis and scavenging them from the host. This flexibility supports growth and virulence making nucleotide metabolism an attractive therapeutic target.
Riya Joshi   +2 more
wiley   +1 more source

Chlamydia : CDC fact sheet [PDF]

open access: yes
Chlamydia is a common STD that can infect both men and women. It can cause serious, permanent damage to a woman\ue2\u20ac\u2122s reproductive system, making it difficult or impossible for her to get pregnant later on.

core  

Deep Understanding of Vaginal Microbiota in HPV‐Related Diseases From a Multi‐Omics Perspective

open access: yesVIEW Medicine, Volume 1, Issue 1, August 2026.
Current understanding of the vaginal microbiota and roles of critical vaginal bacteria, including Lactobacillus and anaerobic pathogens, in human papillomavirus (HPV) infection and HPV‐related diseases from a multi‐omics perspective. ABSTRACT There is a large number of microorganisms in the human body, which are inseparable from human health.
Jianxujie Zheng   +3 more
wiley   +1 more source

The Cost-Effectiveness of Screening for Genital Chlamydial Infection in the UK [PDF]

open access: yes
This PhD thesis explores the cost-effectiveness of Chlamydia trachomatis (CT) screening, in the context of the National Chlamydia Screening Programme (NCSP) currently being implemented in England.
Adams, Elisabeth Jane
core   +1 more source

The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care

open access: yesHealth Technology Assessment, 2015
Background: Partner notification is the process of providing support for, informing and treating sexual partners of individuals who have been diagnosed with sexually transmitted infections (STIs).
Jackie A Cassell   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy